Akanda drops cannabis to focus on fiber subsidiary

The option termination ends Akanda’s right to acquire or use the Gabriola Island site, where it says no product had been cultivated.

Rhea-AI Filing Summary

On September 24, 2026, Akanda Corp. said its board decided it would no longer pursue cannabis cultivation or any future cannabis-related businesses, including planned THC and CBD facilities. The company will instead focus business efforts on the growth and management of its subsidiary, First Towers & Fibers Corp., and potentially other business targets.

Akanda declined the next option payment under its Amended and Restated Option to Purchase agreement with 1107385 B.C. LTD., dated September 22, 2023. The agreement covered an option to purchase a Canadian THC and CBD farming facility on Gabriola Island, British Columbia, and related operations and licenses. Akanda’s right to acquire or use the property has ended; the company said it had not cultivated any product there.

Key Terms

Tetrahydrocannabinol (THC), cannabidiol (CBD), Option Agreement

3 terms

Tetrahydrocannabinol (THC) technical

"planned development of Tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities"

Tetrahydrocannabinol (THC) is the main compound in cannabis that produces the drug’s intoxicating “high” by acting on receptors in the brain and body. It matters to investors because THC determines product demand, medical uses, testing requirements and legal limits—like the engine in a car that both drives performance and shapes safety and regulation—so changes in science, rules or consumer tastes directly affect companies and market value.

cannabidiol (CBD) technical

"planned development of Tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities"

Cannabidiol (CBD) is a naturally occurring compound extracted from cannabis plants that does not produce a "high"; think of it like a single ingredient from a complex recipe. Investors care because CBD is sold in consumer products (oils, creams, supplements) and is subject to shifting rules, demand trends and clinical research that can quickly change a company’s sales outlook and legal risk.

Option Agreement financial

"under its Amended and Restated Option to Purchase agreement"

An option agreement is a contract that gives one party the right, but not the obligation, to buy or sell a specific asset (like company shares or property) at a pre-agreed price within a set time period. Think of it like a reservation or ticket that holds a purchase at today’s terms for later — it matters to investors because it can create potential future value or liability, change ownership stakes, and affect share dilution and company control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What happened to AKAN’s Gabriola Island cannabis facility option?

Akanda declined the next option payment under its agreement with 1107385 B.C. LTD., terminating its right to acquire or use the BC Property on Gabriola Island. Akanda said it had not cultivated any product there.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/25/2026 - 05:28 PM Accepted by SEC EDGAR 09/25/2026 - 05:28 PM Learn about SEC filing dates

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2026

Commission File Number: 001-41324

AKANDA CORP.

(Name of registrant)

c/o Gowling WLG

100 King St. W, Suite 1600

Toronto, ON M5X 1G5

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

☒ Form 20-F ☐  Form 40-F

On September 24, 2026, the Board of Directors of Akanda Corp. (the “Company”) determined that it was no longer going to pursue the cultivation of cannabis or any future cannabis-related businesses, including its planned development of Tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities, and is instead going to focus its business efforts on the growth and management of its First Towers & Fibers Corp. subsidiary, and potentially other business targets.

Accordingly, the Company declined to pay the next option payment due under its Amended and Restated Option to Purchase agreement with 1107385 B.C. LTD., dated September 22, 2023, as amended (the “Option Agreement”), pursuant to which the Company originally acquired an option to purchase a Canadian THC and CBD farming facility located at 1900 Ferne Road, Gabriola Island, British Columbia and related operations and licenses (the “BC Property”). As a result, the Company’s right to acquire or use the BC Property under the Option Agreement has been terminated. The Company had not cultivated any product from the BC Property.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AKANDA CORP.
	(Registrant)
Date: September 25, 2026	By:	/s/ Christopher Cooper
		Name:	Christopher Cooper
		Title:	Chief Executive Officer and Director

2